Oncology Archive

A building with a stone facade displays a sign that reads
Biomarkers for Early Detection of Pancreatic Cancer
A building with a stone facade displays a sign that reads
Collection and Annotation of Biospecimens During Standard of Care and Investigational Treatment of Cancer and Other Diseases Supporting Translational Research
A building with a stone facade displays a sign that reads
Uveal Melanoma, Sarcomas, and NCI-defined Rare Tumors, Biospecimen Collection Protocol
A building with a stone facade displays a sign that reads
Guidance Document for Compassionate Use (CU) Treatment with glofitamab for patients with relapsed/refractory Diffuse Large b-Cell Lymphoma (r/r DLBCL), transformed follicular Lymphoma (tFL) or Primary Mediastinal B-Cell Lymphoma (PMBCL)
A building with a stone facade displays a sign that reads
A Phase 1/2, Open-label, Multi-center Study of the Safety, Tolerability, and Efficacy of GIM-531 as a Single Agent and in Combination With Anti-PD-1 in Advanced Solid Tumors
A building with a stone facade displays a sign that reads
Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors
A building with a stone facade displays a sign that reads
A Phase 1, Open-Label, Multicenter, Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 in Patients With Advanced or Metastatic Prostate Cancer
A building with a stone facade displays a sign that reads
A Phase 2 Study to Investigate the Efficacy and Safety of Acoustic Cluster Therapy With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer
A building with a stone facade displays a sign that reads
First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS)/Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
A building with a stone facade displays a sign that reads
A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)